Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment With a Prospective Post-Marketing Surveillance Study
Drugs - Real World Outcomes - Switzerland
doi 10.1007/s40801-019-0150-8
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2019
Authors
Publisher
Springer Science and Business Media LLC